Bristol-Myers Squibb
BMY
2,280 hedge funds and large institutions have $71.6B invested in Bristol-Myers Squibb in 2025 Q3 according to their latest regulatory filings, with 162 funds opening new positions, 836 increasing their positions, 991 reducing their positions, and 151 closing their positions.
25% more funds holding in top 10
Funds holding in top 10: 16 → 20 (+4)
7% more first-time investments, than exits
New positions opened: 162 | Existing positions closed: 151
1% less funds holding
Funds holding: 2,303 → 2,280 (-23)
3% less call options, than puts
Call options by funds: $1.4B | Put options by funds: $1.44B
2.78% less ownership
Funds ownership: 80.79% → 78.01% (-2.8%)
16% less repeat investments, than reductions
Existing positions increased: 836 | Existing positions reduced: 991
34% less capital inflows, than outflows
Capital inflows: $5.01B | Capital outflows: $7.54B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VanEck Associates
New York
|
+$277M |
| 2 |
Goldman Sachs
New York
|
+$246M |
| 3 |
Two Sigma Investments
New York
|
+$214M |
| 4 |
Two Sigma Advisers
New York
|
+$168M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$165M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$1.58B |
| 2 |
JP Morgan Chase
New York
|
-$830M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$405M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$277M |
| 5 |
Bank of New York Mellon
New York
|
-$196M |
BMY Hedge Fund Activity: Q3 2025 in Review
2,280 of the 7,658 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q3 2025, worth a combined $71.6B — down 5.9% from $76.1B a quarter earlier.
Buyers outnumbered sellers: 162 funds opened new BMY positions and 151 closed out — a net gain of 11 holders — while 836 added to existing stakes and 991 trimmed.
The largest buyer was VanEck Associates, adding an estimated $277M. The largest seller was Capital International Investors, cutting an estimated $1.58B.
- 2,280 institutional investors held Bristol-Myers Squibb (BMY) as of Q3 2025, down from 2,303 in Q2 2025.
- Funds reported $71.6B of Bristol-Myers Squibb stock for Q3 2025, down 5.9% quarter-over-quarter.
- 162 funds opened new Bristol-Myers Squibb positions in Q3 2025 and 151 closed out, a net change of +11 holders.
- The largest Bristol-Myers Squibb buyer in Q3 2025 was VanEck Associates, an estimated $277M added.
- The largest Bristol-Myers Squibb seller in Q3 2025 was Capital International Investors, an estimated $1.58B sold.
Based on aggregated 13F filings for Q3 2025.